论文部分内容阅读
大剂量化疗+自体外周血干细胞(PBSC)移植/异基因骨髓移植(allo-BMT)治疗9例(男6例,女3例,中数年龄47岁)晚期帽状巨细胞淋巴瘤患者。大剂量化疗前7例第一次缓解,其中5例完全缓解(CR),2例部分缓解(PR);2例第二次缓解(CR、PR各1例)。大剂量化疗方案:1例全身照射(TBI,12Gy,分次照射)+环磷酰胺(CTX,120mg/kg·BW),5例TB1(12Gy,分次照射)+CTX(120mg/kg·
High-dose chemotherapy + autologous peripheral blood stem cell (PBSC) transplantation / allogeneic bone marrow transplantation (allo-BMT) treatment of 9 patients (6 males and 3 females, median age 47 years) in patients with advanced cap giant cell lymphoma. Seven patients received first remission before high-dose chemotherapy, including 5 complete remissions (CR), 2 partial remissions (PR), and 2 secondary remissions (1 CR and PR). High-dose chemotherapy regimen: whole body irradiation (TBI, 12 Gy, fractional irradiation) + cyclophosphamide (CTX, 120 mg/kg·BW), 5 TB1 (12 Gy, fractional irradiation) + CTX (120 mg/kg·